Abstract
CD68, a haematopoietic differentiation marker of the monocyte–macrophage lineage, is expressed in various human malignancies including chronic and acute myeloid leukaemia (AML). While the majority of normal CD34+ cells are negative for CD68 expression, CD34+ cells from AML patients produce elevated amounts of this protein. The purpose of this study was to identify CTL epitopes in the human CD68 protein. Mouse CD68 was also analysed to search for epitopes that could be used in murine tumor model. Peptides binding to murine H2b class I molecules were identified and used to stimulate CTL responses from allogeneic donor mice to avoid immunological tolerance. High avidity CTL clones specific for three different peptide epitopes did not kill CD68-expressing murine target cells, indicating that endogenous antigen processing failed to produce sufficient amounts of these peptides. In contrast, allo-restricted human CTL specific for an HLA-A2-binding peptide of CD68 recognised not only picomolar concentrations of peptide, but also displayed low levels of killing against HLA-A2-positive K562 and THP-1 leukemia cell lines and blast cells from AML patients. These data suggest that human leukaemia cells express limited amounts of CD68-derived peptides, and that high avidity CTL capable of recognising sub-picomolar concentrations of peptides are required for efficient killing of leukaemia cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Rosenberg SA . Progress in human tumour immunology and immunotherapy Nature 2001 411: 380–384
Sadovnikova E, Stauss HJ . Peptide-specific cytotoxic T lymphocytes restricted by nonself major histocompatibility complex class I molecules: reagents for tumor immunotherapy Proc Nat Acad Sci USA, 1996 93: 13114–13118
Sadovnikova E, Jopling LA, Stauss HJ . Generation of humantumor-reactive cytotoxic T cells against peptides presented by non-self HLA class I molecules Eur J Immunol 1998 28: 193–200
Strobl H, Scheinecker C, Csmarits B, Majdic O, Knapp W . Flow cytometric analysis of intracellular CD68 molecule expression in normal and malignant haemopoiesis Br J Haematol 1995 90: 774–782
Kurtin PJ, Bonin DM . Immunohistochemical demonstration of the lysosome-associated glycoprotein CD68 (KP-1) in granular cell tumors and shwannomas Hum Path 1994 25: 1172–1178
Gloghini A, Rizzo A, Zanette I, Canal B, Rupolo G, Bassi P, Carbone A . KP1/CD68 expression in malignant neoplasms including lymphomas, sarcomas, and carcinomas Am J Clin Pathol 1995 103: 425–431
Holness CL, da Silva RP, Fawcett J, Gordon S, Simmons DL . Macrosialin, a mouse macrophage-restricted glycoprotein, is a member of the lamp/lgp family J Biol Chem 1993 268: 9661–9666
Ljunggren HG, Karre K . Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism J Exp Med 1985 162: 1745–1759
DeMars R, Chang CC, Shaw S, Reitnauer PJ, Sondel PM . Homozygous deletions that simultaneously eliminate expressions of class I and class II antigens of EBV-transformed B-lymphoblastoid cells. I. Reduced proliferative responses of autologous and allogeneic T cells to mutant cells that have decreased expression of class II antigens Hum Immunol, 1984 11: 77–97
Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K . Establishment and characterization of a human acute monocytic leukemia cell line (THP-1) Int J Cancer 1980 26: 171–176
Pegoraro L, Matera L, Ritz J, Levis A, Palumbo A, Biagini G . Establishment of a Ph1-positive human cell line (BV173) J Natl Cancer Inst 1983 70: 447–453
Knight SC, Farrant J, Bryant A, Edwards AJ, Burman S, Lever A, Clarke J, Webster AD . Non-adherent, low-density cells from human peripheral blood contain dendritic cells and monocytes, both with veiled morphology Immunology 1986 57: 595–603
Yssel H . Role of cytokines in determining human T cell function In: Herzenberg LA, Weir DM, Blackwell C (eds) Weir's Handbook of Experimental Immunology, 5th edn Blackwell Science: USA 1997 p 227.10
Rabinowitz SS, Gordon S . Macrosialin, a macrophage-restricted membrane sialoprotein differentially glycosylated in response to inflammatory stimuli J Exp Med 1991 174: 827–836
Falk K, Rotzschke O, Stevanovic S, Jung G, Rammensee H-G . Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules Nature 1991 351: 290–296
Rammensee H-J, Bachmann J, Emmerich NN, Bachor OA, Stevanovic S . SYFPEITHI: database for MHC ligands and peptide motifs Immunogenetics 1999 50: 213–219
Parker KC, Bednarek MA, Coligan JE . Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains J Immunol 1994 152: 163–175
Gao L, Bellantuono I, Elsasser A, Marley SB, Gordon MY, Goldman JM, Stauss HJ . Selective elimination of leukemic CD34(+) progenitor cells by cytotoxic T lymphocytes specific for WT1 Blood 2000 95: 2198–2203
Bright RK, Kimchi ET, Shearer MH, Kennedy RC, Pass HI . SV40 Tag-specific cytotoxic T lymphocytes generated from the peripheral blood of malignant pleural mesothelioma patients Cancer Immunol Immunother 2002 95: 682–690
Stanislawski T, Voss RH, Lotz C, Sadovnikova E, Willemsen RA, Kuball J, Ruppert T, Bolhuis RL, Melief CJ, Huber C, Stauss HJ, Theobald M . Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer Nat Immunol 2001 2: 962–970
Acknowledgements
The work was supported by the Wellcome Trust Collaborative Research Initiative Grant 054533.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sadovnikova, E., Parovichnikova, E., Savchenko, V. et al. The CD68 protein as a potential target for leukaemia-reactive CTL. Leukemia 16, 2019–2026 (2002). https://doi.org/10.1038/sj.leu.2402635
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402635
Keywords
This article is cited by
-
Multiple isolated extramedullary relapse of acute promyelocytic leukemia after allogeneic hematopoietic stem cell transplant: a case report and review of literature
SpringerPlus (2013)
-
NOD/scid IL-2Rgnull mice: a preclinical model system to evaluate human dendritic cell-based vaccine strategies in vivo
Journal of Translational Medicine (2012)
-
Clinical evaluation of cellular immunotherapy in acute myeloid leukaemia
Cancer Immunology, Immunotherapy (2011)
-
Antigen-specific cellular immunotherapy of leukemia
Leukemia (2005)